AxoGen, Inc. (AXGN)
NASDAQ: AXGN · Real-Time Price · USD
14.67
+0.11 (0.76%)
At close: Sep 19, 2024, 4:00 PM
14.55
-0.12 (-0.82%)
After-hours: Sep 19, 2024, 4:50 PM EDT

AxoGen Market Cap

AxoGen has a market cap or net worth of $642.98 million as of September 19, 2024. Its market cap has increased by 143.28% in one year.

Market Cap
642.98M
Enterprise Value
693.34M
1-Year Change
143.28%
Ranking
Category
Stock Price
$14.67

Market Cap Chart

Since December 1, 1998, AxoGen's market cap has increased from $12.20M to $642.98M, an increase of 5,170.35%. That is a compound annual growth rate of 16.60%.

History

DateMarket Cap% Change
Sep 18, 2024638.20M117.07%
Dec 29, 2023294.00M-30.33%
Dec 30, 2022422.00M8.37%
Dec 31, 2021389.40M-45.79%
Dec 31, 2020718.30M1.73%
Dec 31, 2019706.10M-10.63%
Dec 31, 2018790.10M-16.55%
Dec 29, 2017946.80M219.76%
Dec 30, 2016296.10M98.19%
Dec 31, 2015149.40M113.43%
Dec 31, 201470.00M-10.14%
Dec 31, 201377.90M159.67%
Dec 31, 201230.00M1.35%
Dec 30, 201129.60M97.33%
Dec 31, 201015.00M-12.79%
Dec 31, 200917.20M45.76%
Dec 31, 200811.80M118.52%
Dec 31, 20075.40M100.00%
Dec 29, 20062.70M28.57%
Dec 30, 20052.10M-65.00%
Dec 31, 20046.00M87.50%
Dec 31, 20033.20M60.00%
Dec 31, 20022.00M-60.78%
Dec 31, 20015.10M-30.14%
Dec 29, 20007.30M15.87%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Cytek Biosciences 665.42M
Scholar Rock Holding 661.87M
Astria Therapeutics 655.10M
SI-BONE 653.76M
Mereo BioPharma Group 648.21M
Humacyte 637.33M
Simulations Plus 629.24M
Revance Therapeutics 627.89M
Market Cap Rankings